Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica

Multiple Sclerosis

Volumn 15, Issue 12, 2009, Pages 1411-1421

  Li, Wei ^a   Minohara, Motozumi ^a   Piao, Hua ^a   Matsushita, Takuya ^a   Masaki, Katsuhisa ^a   Matsuoka, Takeshi ^a   Isobe, Noriko ^a   Su, Jen Jen ^a   Ohyagi, Yasumasa ^a   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Aquaporin 4; Helicobacter pylori; Japanese; Multiple sclerosis; Neuromyelitis optica; Neutrophil activating protein; Opticospinal

Indexed keywords

AQUAPORIN 4 ANTIBODY; BACTERIUM ANTIBODY; HELICOBACTER PYLORI NEUTROPHIL ACTIVATING PROTEIN ANTIBODY; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CONVENTIONAL MULTIPLE SCLEROSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME IMMUNOASSAY; FEMALE; HELICOBACTER INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTICOSPINAL MULTIPLE SCLEROSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; AQUAPORIN 4; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; AUTOIMMUNITY; BACTERIAL PROTEINS; DISABILITY EVALUATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; PEROXIDASE; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 72749086379     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509348961     Document Type: Article

References (37)

1. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003 ; 2: 117-127.
2. Kira J., Yamasaki K., Horiuchi I., Ohyagi Y., Taniwaki T., Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 1999 ; 166: 53-57.
3. Osoegawa M., Kira J., Fukazawa K., et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 2009 ; 15: 159-173.
4. Blaser MJ Helicobacter pylori: microbiology of a slow bacterial infection. Trends Microbiol 1993 ; 1: 255-259.
5. Graham DY Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991 ; 6: 105-113.
6. Horiuchi T., Ohkusa T., Watanabe M., Kobayashi D., Miwa H., Eishi Y. Helicobacter pylori DNA in drinking water in Japan. Microbiol Immunol 2001 ; 45: 515-519.
7. Asaka M., Kimura T., Kudo M., et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992 ; 102: 760-766.
8. Li W., Minohara M., Sun JJ, et al. Helicobacter pylori is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 2007 ; 184: 227-231.
9. Wender M. Prevalence of Helicobacter pylori infection among patients with multiple sclerosis. Neurol Neurochir Pol 2003 ; 37: 45-48. (in Polish).
10. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 ; 364: 2106-2112.
11. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005 ; 202: 473-477.
12. Matsuoka T., Matsushita T., Kawano Y., et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007 ; 130: 1206-1223.
13. Tanaka K., Tani T., Tanaka M., et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007 ; 13: 850-855. (Pubitemid 351540855)
14. de Luis DA, Varela C., de La Calle H., et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998 ; 26: 259-263.
15. Emilia G., Longo G., Luppi M., et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001 ; 97: 812-814.
16. Gasbarrini A., Franceschi F., Tartaglione R., et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998 ; 352: 878. (Pubitemid 28416725)
17. Zentilin P., Savarino V., Garnero A., Accardo S., Seriolo B. Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? Gastroenterology 1999 ; 116: 503-504.
18. Montecucco C., de Bernard M. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (Vac A) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect 2003 ; 5: 715-721.
19. Lucchinetti CF, Mandler RN, McGavern D., et al. A role for humoral mechanisms in the pathogenesis of Devics neuromyelitis optica. Brain 2002 ; 125: 1450-1461.
20. Ishizu T., Osoegawa M., Mei FJ, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005 ; 128: 988-1002.
21. Minohara M., Matsuoka T., Li W., et al. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol 2006 ; 178: 156-160.
22. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
23. Kira J., Kanai T., Nishimura Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996 ; 40: 569-574.
24. Matsushita T., Isobe N., Matsuoka T., et al. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler 2009 ; 15: 834-847.
25. Wingerchuk DM, Hogancamp WF, OBrien PC, Weinshenker BG The clinical course of neuromyelitis optica (Devics syndrome). Neurology 1999 ; 53: 1107-1114.
26. Kurtzke JF Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 ; 33: 1444-1452.
27. Ishizu T., Kira J., Osoegawa M., et al. Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. J Neurol Sci 2009 ; 280: 22-28.
28. Fukazawa T., Hamada T., Tashiro K., Moriwaka F., Yanagihara T. Acute transverse myelopathy in multiple sclerosis. J Neurol Sci 1990 ; 100: 217-222.
29. Barkhof F., Filippi M., Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997 ; 120: 2059-2069.
30. Kurtzke J., Page WF Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS. Neurology 1997 ; 48: 204-213.
31. Doi H., Matsushita T., Isobe N., et al. Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody. Mult Scler 2009 ; 15: 304-310.
32. Tanaka M., Matsushita T., Tateishi T., et al. Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 2008 ; 71: 974-981.
33. Teneberg S., Miller-Podraza H., Lampert HC, et al. Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori. J Biol Chem 1997 ; 272: 19067-19071.
34. Zanotti G., Papinutto E., Dundon W., et al. Structure of the neutrophil-activating protein from Helicobacter pylori. J Mol Biol 2002 ; 323: 125-130.
35. Algood HM, Gallo-Romero J., Wilson KT, Peek Jr RM, Cover TL Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol 2007 ; 51: 577-586.
36. Caruso R., Pallone F., Monteleone G. Emerging role of IL-23/IL-17 axis in H pylori-associated pathology. World J Gastroenterol 2007 ; 13: 5547-5551.
37. Calamita G. The Escherichia coli aquaporin-Z water channel. Mol Microbiol 2000 ; 37: 254-262.